Hong-Ping Guan, PhD
CSO & Co-Founder
Dr. Hong-Ping Guan is a seasoned scientist with over two decades of experience in both basic and pharmaceutical research focused on diabetes and cardiometabolic diseases. While working at the Merck Research Laboratories, he significantly contributed to the advancement of various programs, such as glucagon receptor antagonists, AMPK modulators, and MASH therapeutics. His expertise covers target biology, in vivo pharmacology, and mechanistic research, which have supported several assets in clinical stages.
Hong-Ping earned his Bachelor of Medicine from Beijing Medical University (Peking University Health Science Center) and his Ph.D. in Pharmacology from the University of Pennsylvania. He completed postdoctoral training at UT Southwestern Medical Center as a Pfizer Fellow of the Life Sciences Research Foundation.
